CNSP — CNS Pharma

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a ...

CNS Pharmaceuticals Inc is a biotechnology company focused on developing therapies for serious diseases in neurology and oncology. The company is building a high-value pipeline for neurology and oncology indications. Its new corporate includes pivoting from a singular focus on glioblastoma multiforme and exploring out-licensing opportunities for its legacy assets, TPI 287 and Berubicin.

Industry
PHARMACEUTICAL PREPARATIONS
Sector
Healthcare
Exchange
NASD
First trade date
2019-11-08

The interactive platform loads with JavaScript. Research tools are for informational purposes.